Parenteral Drugs (India) Limited - Company Profile

Q: Where is Parenteral Drugs (India) Limited headquartered?

Parenteral Drugs (India) Limited is headquartered at E210, 2Nd Floor, Crystal Plaza, Off New Link Road Andheri West, Mumbai, Maharashtra, 400053.

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1983.

1983 Mumbai, Maharashtra, India Active

Last Updated: December 21, 2025

Access Report

About Parenteral Drugs (India) Limited

Parenteral Drugs (India) Limited, a active public limited company, was established on 13 December 1983 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24100MH1983PLC126481. Registered under ROC Roc Mumbai. it is listed on BSE: 524689 and NSE: PDPL. It has an authorized capital of ₹50.00 Cr and a paid-up capital of ₹29.82 Cr.

Formerly known as Parenteral Drugs (India) Private Limited. It upholds a compliant status. Employing 610 professional, Its leadership includes Manish Verma (Director), Anil Mittal (Director), Vinod Kumar Gupta (Nodal Officer). Past directors included Sandeep Vyas, Manish Verma, Manohar Lal Gupta. It holds ₹547.55 Cr open charges and ₹96.32 Cr settled loans. Its latest AGM occurred on 24 September 2021, with the balance sheet filed on 31 March 2021. It is based at E/210, 2Nd Floor, Crystal Plaza, Off New Link Road Andheri West, Mumbai, Maharashtra, 400053.

Company Details

CIN/LLPIN
L24100MH1983PLC126481
Registration Number
126481
Incorporation Date
13 December 1983
Authorized Capital
₹50.00 Cr
Paid-Up Capital
₹29.82 Cr
ROC Code
Roc Mumbai
Listing Status
Listed (BSE: 524689, NSE: PDPL)
Company Status
Active

Key Metrics

Authorised Capital ₹ 50.00 Cr as on 21-12-2025
Paid Up Capital ₹ 29.82 Cr as on 21-12-2025
Company Age 42 Year, 2 Months
Last Filing with ROC 31 Mar 2021
Open Charges ₹ 547.55 Cr as on 21-12-2025
Satisfied Charges ₹ 96.32 Cr as on 21-12-2025
Revenue Growth **** -61.93% (FY 2021)
Profit Growth **** -6.70% (FY 2021)
Ebitda **** 19.83% (FY 2021)
Net Worth -21.65% (FY 2021)
Total Assets **** 2.97% (FY 2021)

Comprehensive Company Insights

Explore comprehensive insights into Parenteral Drugs (India) Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Parenteral Drugs (India) Limited?

Current Directors

Name	Designation	Appointment Date	Status
Manish Verma	Director	29 Jun 2018	Current
Anil Mittal	Director	30 Jan 2008	Current
Vinod Kumar Gupta	Nodal Officer	17 Oct 2020	Current
Kavish Vijayvargiya	Director	19 Mar 2025	Current
Chhaya Gupta	Director	02 Feb 2022	Current
Govind Sharma	Director	19 Mar 2025	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	13 Jun 2018	Past
Pramod Abcsdd	Additional Director	29 Sep 2018	Past
Pramod Abcsdd	Managing Director	31 Dec 2008	Past
Pramod Abcsdd	Irp/Rp/Liquidator	06 Mar 2025	Past
Pramod Abcsdd	Nominee Director	30 Jun 2014	Past
Pramod Abcsdd	Whole-Time Director	14 Aug 2018	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Parenteral Drugs (India).

Parenteral Drugs (India) Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 61.93% decrease. The company also saw a slight decrease in profitability, with a 6.7% decrease in profit. The company's net worth observed a substantial decline by a decrease of 21.65%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-61.93%

*******

Revenue from Operations

*******

-61.83%

*******

Total Assets

*******

2.97%

*******

Profit or Loss

*******

-6.70%

*******

Net Worth

*******

-21.65%

*******

EBITDA

*******

19.83%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Parenteral Drugs (India)?

In 2021, Parenteral Drugs (India) had a promoter holding of 73.28% and a public holding of 26.73%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹5,475,500,000.00

Satisfied Charges

₹963,200,000.00

Charges Breakdown by Lending Institutions

Others : 547.55 Cr

Latest Charge Details

Date	Lender	Amount	Status
07 Apr 2015	Others	₹95.63 Cr	Open
21 Dec 2012	Others	₹56.50 Cr	Open
26 Sep 2007	Others	₹15.28 Cr	Open
26 Sep 2007	Others	₹5.80 M	Open
12 Mar 2007	Others	₹7.60 M	Open

Explore comprehensive loan charge details -

How Many Employees Work at Parenteral Drugs (India)?

Parenteral Drugs (India) has a workforce of 610 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Parenteral Drugs (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parenteral Drugs (India)'s trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Parenteral Drugs (India)

Recent Activity within the Organization

Director Appointment

Progress on Ashok Kumar Patidar was appointed as a Additional Director was appointed as a Additional Director on 17 Jul 2025 & has been associated with this company since 7 months 13 days . was documented.
17 Jul 2025
Director Appointment

Kavish Vijayvargiya was appointed as a Director was appointed as a Director on 19 Mar 2025 & has been associated with this company since 11 months 11 days . was recorded as a recent event.
19 Mar 2025
Director Appointment

Progress on Govind Sharma was appointed as a Director was appointed as a Director on 19 Mar 2025 & has been associated with this company since 11 months 11 days . was documented.
19 Mar 2025
Charges

The activity A charge with Others of Rs. 56.50 Cr registered on 21 Dec 2012 with Charge ID 10399402 was modified on 05 Feb 2024. was completed.
05 Feb 2024
Charges

A charge with Others of Rs. 0.58 Cr registered on 26 Sep 2007 with Charge ID 10223861 was modified on 05 Feb 2024. was recorded as a recent event.
05 Feb 2024
Charges

A charge with Others of Rs. 95.63 Cr registered on 07 Apr 2015 with Charge ID 10562129 was modified on 12 Oct 2023. was recorded as a recent event.
12 Oct 2023

Explore recent activity and updates - View Recent Activity